Literature DB >> 6253004

The value of polymixin B in endotoxaemia due to experimental obstructive jaundice and mesenteric ischaemia.

C J Ingoldby.   

Abstract

The role of polymixin B in endotoxaemia due to obstructive jaundice and mesenteric ischaemia has been examined. Rats made jaundiced by common bile duct ligation were challenged with intragastric endotoxin. Rats given polymixin B infusions had improved survival (11/15) compared with controls (4/14). Mesenteric ischaemia was induced in rats by clipping the mesenteric artery. Limulus assay revealed marked endotoxaemia in controls. Polymixin B infusions reduced the degree of endotoxaemia. Pre-treatment with non-absorbable intestinal antibiotics markedly reduced endotoxaemia. Polymixin B infusions gave no advantage of survival (3/10) compared with controls (2/10), but all animals pre-treated with intestinal antibiotics survived (12/12). The difference in results found between obstructive jaundice and mesenteric ischaemia may be due to different degrees of endotoxaemia. Polymixin B may have a place in the prophylaxis of endotoxaemia in clinical obstructive jaundice.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6253004     DOI: 10.1002/bjs.1800670812

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  7 in total

1.  Acute intestinal ischaemia.

Authors:  A Marston
Journal:  BMJ       Date:  1990-11-24

2.  Lactulose inhibits endotoxin induced tumour necrosis factor production by monocytes. An in vitro study.

Authors:  J W Greve; D J Gouma; P A von Leeuwen; W A Buurman
Journal:  Gut       Date:  1990-02       Impact factor: 23.059

3.  Polymyxin B sulphate protects cats against the haemodynamic and metabolic effects of E. coli endotoxin.

Authors:  B Hughes; B R Madan; J R Parratt
Journal:  Br J Pharmacol       Date:  1981-11       Impact factor: 8.739

4.  Endotoxemia and human liver transplantation.

Authors:  I Yokoyama; S Todo; T Miyata; R Selby; A G Tzakis; T E Starzl
Journal:  Transplant Proc       Date:  1989-10       Impact factor: 1.066

Review 5.  Rescuing the Last-Line Polymyxins: Achievements and Challenges.

Authors:  Sue C Nang; Mohammad A K Azad; Tony Velkov; Qi Tony Zhou; Jian Li
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

6.  Enteric coated polymyxin B in the treatment of hyperammonemia and endotoxemia in liver cirrhosis.

Authors:  Y Adachi; M Enomoto; M Adachi; M Suwa; Y Nagamine; T Nanno; T Hashimoto; H Inoue; T Yamamoto
Journal:  Gastroenterol Jpn       Date:  1982-12

Review 7.  Anti-endotoxin Properties of Polymyxin B-immobilized Fibers.

Authors:  Tohru Tani; Tomoharu Shimizu; Masaji Tani; Hisataka Shoji; Yoshihiro Endo
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.